Demographics of Hemophilia in Developing Countries

 

 Buy Article Permissions and Reprints

ABSTRACT

Demographic datasets pertaining to populations are extremely valuable tools in healthcare planning. They are vital in setting priorities, allocation of resources, measurement of outcomes, and comparison of alternate approaches. Countries with emerging economies especially need information regarding targeted populations when initiating programs designed to deliver care to persons with chronic conditions such as hemophilia. The problems associated with data collection in these countries are huge but surmountable. The World Federation of Haemophilia (WFH) Global Survey provides a valuable synopsis of current global data on hemophilia patients and has provided insight into the extent of the problem with hemophilia worldwide. More and more countries recognize the uses of these data and have established or are in the process of establishing registries for persons with hemophilia to try and improve the quality of the information provided to the WFH. This information will most certainly assist in guiding the future of hemophilia care in these countries with emerging economies.

REFERENCES

• 1 Report of a Joint WHO/WFH meeting .Control of Haemophilia: haemophilia care in the developing world. Geneva, June 17-17, 1997 (WHO/GHN/WFH/WG/98.3) 1997
  Google Scholar
• 2 World Development Indicators [on CD-ROM] .1st ed., April 1999. Washington, DC; World Bank 1999
  Google Scholar
• 3 The World Fact Book .Washington, DC; Central Intelligence Agency 1997
• 4 Global Survey on Hemophilia .Montreal, Canada; WFH 1999
• 5 Smith P S, Keys N C, Forman E N. Socioeconomic evaluation of a state funded comprehensive hemophilia-care program.  N Engl J Med. 1982;  306 575-659
  PubMedGoogle Scholar
• 6 Smith P S. Levine PH and directors of eleven participating hemophilia centers. The benefits of comprehensive care of hemophilia: a five-year study of outcomes.  Am J Public Health. 1984;  74 616-617
  PubMedGoogle Scholar
• 7 Robillard L. Venezuela: an Operation Improvement success story.  Haemophilia World. 1998;  5 1-3
  PubMedGoogle Scholar
• 8 Lee C A. Towards achieving global haemophilia care-World Federation of Hemophilia Programs.  Haemophilia. 1998;  4 463-473
  CrossrefPubMedGoogle Scholar
• 9 Evatt B L, Robillard L. Establishing haemophilia care in developing countries: using data to overcome the barrier of pessimism.  Haemophilia. 2000;  6 131-134
  CrossrefPubMedGoogle Scholar
• 10 Evatt B L. Public health and international health-care development for persons with haemophilia. Operation Improvement and Operation Access.  Haemophilia. 1998;  4 491-497
  CrossrefPubMedGoogle Scholar
• 11 Chandy M. Management of haemophilia in developing countries with available resources.  Haemophilia. 1995;  1(suppl 1) 44-48
  PubMedGoogle Scholar
• 12 Srivastava A, Chauansumrit A, Chandy M, Duraisamy G, Karabus C. Management of haemophilia in the developing world.  Haemophilia. 1998;  4 474-480
  CrossrefPubMedGoogle Scholar
• 13 Global Survey on Hemophilia .Montreal, Canada; WFH 2000
• 14 Global Survey on Hemophilia .Montreal, Canada; WFH 2001
• 15 Global Survey on Hemophilia .Montreal, Canada; WFH 2002
• 16 Soucie J M, Evatt B E, Jackson D. and the Hemophilia Surveillance System Project Investigators . Occurrence of hemophilia in the United States.  Am J Hematol. 1998;  59 288-294
  CrossrefPubMedGoogle Scholar
• 17 Evatt B L. Observations from Global Survey 2001: an emerging database for progress.  Haemophilia. 2002;  8 1-4
  PubMedGoogle Scholar
• 18 Soucie J M, Nuss R, Evatt B and the Hemophilia Surveillance System Project Investigators et al. Mortality among males with hemophilia: relations with source of medical care.  Blood. 2000;  96 437-442
  PubMedGoogle Scholar
• 19 WFH Global Forum on the Safety and Supply of Hemophilia Treatments and Products .Proceedings of the World Federation of Haemophilia. April 10-11, 2000 Montreal, Canada;
  Google Scholar
• 20 Soucie J M, Richardson L C, Evatt B L for the Hemophilia Surveillance System Project Investigators et al.. Risk factors for infection with HBV and HCV in a large cohort of hemophiliac males.  Transfusion. 2001;  41 338-343
  CrossrefPubMedGoogle Scholar
• 21 Evatt B L, Austin H, Leon G, Ruiz-Saez A, de Bosch N. Haemophilia therapy: assessing the cumulative risk of HIV exposure by cryoprecipitate.  Haemophilia. 1999;  5 295-300
  CrossrefPubMedGoogle Scholar
• 22 Srivastava A, Chuansumrit A, Chandy M, Duraiswamy G, Karabus C. Management of haemophilia in the developing world.  Haemophilia. 1998;  4 474-480
  CrossrefPubMedGoogle Scholar

Bruce L EvattM.D. 

Centers for Disease Control, 1600 Clifton Rd.

NE, E64, Atlanta, GA 30333

Email: ble2@mindspring.com